diaDexus, Inc. (DDXS) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 29 transactions totaling $129.2K, demonstrating a bullish sentiment with $45.2K in net insider flow. The most recent transaction on Feb 5, 2015 involved a transaction of 218,182 shares valued at $0.
No significant insider buying has been recorded for DDXS in the recent period.
No significant insider selling has been recorded for DDXS in the recent period.
Based on recent SEC filings, insider sentiment for DDXS is bullish with an Insider Alignment Score of 67/100 and a net flow of $45.2K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at diaDexus, Inc. (DDXS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading DDXS stock, having executed 29 transactions in the past 90 days. The most active insider is Life Sciences Capital Fund Lp Burrill (Executive), who has made 7 transactions totaling $87.2K.
Get notified when executives and directors at DDXS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 5, 2015 | F. Rafield Lori Phd | Executive | Award | 218,182 | $N/A | $0 | |
| Apr 28, 2014 | Viret Jean-frederic | Executive | Option Exercise | 2,108 | $0.28 | $590 | |
| Dec 4, 2013 | Emilia Zychlinsky Bulaevsky | Executive | Option Exercise | 20,000 | $0.29 | $5.8K | |
| Oct 30, 2013 | Burrill Steven | Executive | Other | 49,917 | $N/A | $0 | |
| Oct 30, 2013 | Burrill Steven | Executive | Other | 1,098,124 | $N/A | $0 | |
| Oct 30, 2013 | Burrill Steven | Executive | Other | 239,985 | $N/A | $0 | |
| Oct 30, 2013 | Burrill Steven | Executive | Other | 5,279,442 | $N/A | $0 | |
| Oct 30, 2013 | Burrill Steven | Executive | Other | 5,519,427 | $N/A | $0 | |
| Sep 3, 2013 | Michael Richey Robert | Executive | Option Exercise | 42,421 | $0.26 | $11.0K | |
| Aug 6, 2013 | F. Rafield Lori Phd | Executive | Award | 9,750 | $N/A | $0 | |
| Aug 6, 2013 | Drexler Karen | Executive | Award | 6,500 | $N/A | $0 | |
| Aug 6, 2013 | H. Galligan Andrew | Executive | Award | 6,500 | $N/A | $0 | |
| Aug 6, 2013 | P. Panek James | Executive | Award | 6,500 | $N/A | $0 | |
| Aug 6, 2013 | W. Patrick Charles | Executive | Award | 6,500 | $N/A | $0 | |
| Aug 6, 2013 | Y. Olukotun Adeoye | Executive | Award | 5,958 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 7 | $87.2K | 44.0% |
Exercise(M) | 7 | $68.9K | 34.8% |
Sale(S) | 3 | $42.0K | 21.2% |
Award(A) | 7 | $0 | 0.0% |
Other(J) | 5 | $0 | 0.0% |
Insiders at diaDexus, Inc. are accumulating shares at an accelerated pace. With 13 insiders making 29 transactions totaling $87.2K in purchases versus $42.0K in sales, the net buying activity of $45.2K signals strong executive confidence. Life Sciences Capital Fund Lp Burrill (Executive) leads the buying activity with $87.2K in transactions across all time.